Evaluating the technical use of a Fitbit during an intervention for patients with pulmonary arterial hypertension with quality of life as primary endpoint: Lessons learned from the UPHILL study

Chermaine T Kwant; Frances S de Man; Harm J Bogaard; Anton Vonk Noordegraaf

doi:10.1002/pul2.12381

Evaluating the technical use of a Fitbit during an intervention for patients with pulmonary arterial hypertension with quality of life as primary endpoint: Lessons learned from the UPHILL study

Pulm Circ. 2024 Jun 14;14(2):e12381. doi: 10.1002/pul2.12381. eCollection 2024 Apr.

Authors

Chermaine T Kwant¹, Frances S de Man¹, Harm J Bogaard¹, Anton Vonk Noordegraaf¹

Affiliation

¹ Departments of Pulmonary Medicine, Amsterdam UMC, Amsterdam Cardiovascular Sciences Vrije Universiteit Amsterdam Amsterdam The Netherlands.

Abstract

This article examines technical use of Fitbit during an intervention for pulmonary hypertension (PAH)-patients. Technical issues with the device led to data being unavailable(37.5%). During intervention objective daily physical activity (DPA) decreased and subjective DPA increased. This emphasizes that an assessment of DPA in PAH requires incorporating both objective and subjective measurements.

Keywords: daily physical activity; pulmonary hypertension; smartwatch; technical use.